Monashee Investment Management »

Ionis Pharmaceuticals shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $801k 20k 40.06

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Arthur J. Gallagher & Co. (AJG)
Landbridge Company Cl A (LB)
Sable Offshore Corp Com Shs (SOC)
Boeing Company (BA)
Amer Sports Com Shs (AS)
Abacus Life Cl A (ABL)
Biodesix (BDSX)

View all positions for Monashee Investment Management

Top funds holding Ionis Pharmaceuticals

FMR
Vanguard Group
T. Rowe Price Investment Management
BlackRock
Capital World Investors
Wellington Management Company
Bellevue Group
State Street Corporation
T. Rowe Price Associates
Tweedy, Browne Company
OrbiMed Advisors
Geode Capital Management
Citadel Advisors
Deep Track Capital
UBS Group

View all funds holding Ionis Pharmaceuticals